Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

Update Il y a 4 ans
Reference: NCT00228969

Woman and Man

Extract

The primary objective of this study is to evaluate the efficacy, safety, and tolerability of 4 daily doses of RWJ-333369 as adjunctive treatment of refractory partial epilepsy in subjects who are between 18 and 70 years of age, inclusive


Inclusion criteria

  • Refractory Epilepsy


Links